Zion Market Research

Global Proteomics Market Is Expected to Reach Around USD 43.7 Billion by 2025

Global proteomics market expected to generate around USD 43.7 billion by 2025, at a CAGR of around 14.9% between 2019 and 2025. Proteomics encompasses the extensive learning of proteins, their assembly, and physiological part or roles. Proteins are essential cellular constituents or biomolecules in living organisms.

 

Sarasota, FL -- (SBWIRE) -- 04/09/2019 -- Zion Market Research has published a new report titled "Proteomics Market by Component (Reagents and Instruments) and by Application (Disease Diagnosis, Drug Discovery, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025". According to the report, global proteomics market was approximately USD 16.6 billion in 2018 and is expected to generate around USD 43.7 billion by 2025, at a CAGR of around 14.9% between 2019 and 2025.

Download Free PDF Research Report Brochure @ https://www.zionmarketresearch.com/requestbrochure/proteomics-market

Proteomics encompasses the extensive learning of proteins, their assembly, and physiological part or roles. Proteins are essential cellular constituents or biomolecules in living organisms. Proteomics reveals substantial biological information that plays an important role in disease diagnosis and drug discovery. Developments in mass spectrometry, protein fractionation practices, and bioinformatics have increased the significance of proteomics. The use of proteomics has transformed drug discovery entirely.

The growing demand for personalized medicines, increasing expenditure on research and development by the leading market players, various technological advancements, rising awareness regarding multiple applications of proteomics, increasing case of genetic disorders, the ability of proteomics to bridge the gap between cellular behavior and genome expression, and rapid implementation of latest technologies in developed regions are majorly driving the growth of the global proteomics market. Governmental efforts to fast track research and development activities will create new opportunities for the market players in the global proteomics market in the years ahead. However, the high cost of instruments, the dearth of skilled research professionals, and lack of awareness regarding proteomics and its applications in developing regions may restrict the global proteomics market.

The global proteomics market is split into component and application. Based on the component, the proteomics market is segmented into reagents and instruments. The reagents segment held the largest market share in 2018, due to the rising product use for separation of protein from intricate mixtures and additional proteome investigation measures. Reagents are sub-segmented into spectroscopy, microarray, X-ray crystallography, electrophoresis, chromatography, protein fractionation reagents, immunoassay, and services. Instruments are sub-segmented into spectrometry, protein microarray, chromatography, surface plasmon resonance, electrophoresis, protein fractionation systems, and X-ray crystallography. The microarray sub-segment accounted for the largest market share in 2017. The application segment is divided into disease diagnosis, drug discovery, and others. Drug discovery held the largest market share in 2018, due to multiple advantages offered by proteomics technology in the drug discovery process.

By region, North America will be the leading region over the forecast time period in the global proteomics market. The growing implementation of tailored medicine, positive government initiatives, huge investments in research and development, increasing investments made by academic institutions in proteomics and genomics research, and the presence of the state-of-the-art healthcare facilities are driving the region's proteomics market. Europe will be the second largest proteomics market globally in the future, owing to the presence of skilled researchers, high R&D investment made by leading companies, increasing geriatric population, the rising prevalence of chronic disorders, and positive reimbursement scenario. The Asia Pacific proteomics market will grow at a speedy rate over the forecast time period due to the rising incidence of chronic diseases, growing interest in proteomics, increasing research and development on proteomics applications, and growing use of proteomics in disease diagnosis and therapy.

Request Free Sample Report @ https://www.zionmarketresearch.com/sample/proteomics-market

Some key players of the global proteomics market are Agilent Technologies, Thermo Fisher Scientific Corporation, Luminex Corporation, Bio-Rad Laboratories, Inc., Danaher Corporation, Inc., GE Healthcare, Caprion Proteomics Inc., PerkinElmer, Inc., and Waters Corporation, among others.

This report segments the global proteomics market into:

Global Proteomics Market: By Component

Reagents
Spectroscopy
Microarray
X-Ray Crystallography
Electrophoresis
Chromatography

Protein Fractionation Reagents
Immunoassay
Services
Instruments
Spectrometry
Protein Microarray
Chromatography
Surface Plasmon Resonance
Electrophoresis
Protein Fractionation Systems
X-ray Crystallography

Global Proteomics Market: By Application

Disease Diagnosis
Drug Discovery
Others

Inquiry more about this report @ https://www.zionmarketresearch.com/inquiry/proteomics-market

Global Proteomics Market: By Region

North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
The Middle East and Africa